Sign In
Buy CIZN
$10.74
+0.0900 (+0.85%)
At Close: Jul 31, 2026
Vanda Pharmaceuticals Announces Participation in the 2026 Citizens Life Sciences Conference
04:35pm, Thursday, 26'th Feb 2026
WASHINGTON, Feb. 26, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the 2026 Citizens Life Sciences Conference in Miami on
Ethos to Participate in The Citizens Technology Conference
04:06pm, Thursday, 26'th Feb 2026
AUSTIN, Texas, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Ethos (NASDAQ: LIFE), a leading life insurance technology company democratizing access to life insurance, today announced that Peter Colis, Co-founder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of First Citizens BancShares, Inc. - FCNCA
03:12pm, Thursday, 26'th Feb 2026
NEW YORK, Feb. 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of First Citizens BancShares, Inc. ("First Citizens" or the "Company") (NASDAQ: FCNCA). Such inves
Zevra Therapeutics to Present at the Citizens Life Sciences Conference
07:30am, Wednesday, 25'th Feb 2026
CELEBRATION, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of First Citizens BancShares, Inc. - FCNCA
05:35pm, Tuesday, 24'th Feb 2026
NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of First Citizens BancShares, Inc. (“First Citizens” or the “Company”) (NASDAQ: FCNCA).
USA TODAY Co. to Present at the Citizens JMP Technology Conference
07:30am, Tuesday, 24'th Feb 2026
NEW YORK, NY--(BUSINESS WIRE)--USA TODAY Co., Inc. ("USA TODAY Co.", "we", "us", "our", or the "Company") (NYSE: TDAY) today announced that its Chairman and Chief Executive Officer, Michael Reed, and
Citizens Financial Group to Participate at the 2026 RBC Capital Markets Financial Institutions Conference
04:05pm, Monday, 23'rd Feb 2026
PROVIDENCE, R.I.--(BUSINESS WIRE)--Citizens Financial Group, Inc. (NYSE: CFG) announced today that President Brendan Coughlin and Chief Financial Officer Aunoy Banerjee will participate at the RBC Cap
First Citizens Seeks New Mergers to Cross Growth Threshold
06:06pm, Friday, 20'th Feb 2026
First Citizens BancShares is looking to make acquisitions that will give it the scale needed to deal with the additional regulations that come into effect when a bank reaches $250 billion in assets, B
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of First Citizens BancShares, Inc. - FCNCA
08:04pm, Thursday, 19'th Feb 2026
NEW YORK, Feb. 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of First Citizens BancShares, Inc. ("First Citizens" or the "Company") (NASDAQ: FCNCA). Such inve
FCNCN: A 6.625% Fixed Rate -Reset Preferred IPO From First Citizens BancShares
04:32pm, Thursday, 19'th Feb 2026
First Citizens BancShares (FCNCA) has issued a 6.625% non-cumulative fixed rate-reset preferred stock, Series E (FCNCN), now trading near par. FCNCA's capital structure remains robust, with CET1 at 11
AV, Inc. to Present at Citizens Technology Conference
02:07pm, Wednesday, 18'th Feb 2026
ARLINGTON, Va.--(BUSINESS WIRE)---- $AVAV #AVAV--AeroVironment, Inc. (“AV”) (NASDAQ: AVAV) will participate in the upcoming Citizens Technology Conference in San Francisco, California. AV Executiv
Citizens Financial Strengthens Advisory Platform With Matrix Deal
01:36pm, Wednesday, 18'th Feb 2026
CFG is set to expand its advisory platform through the planned acquisition of Matrix, expanding expertise in Downstream Energy & Convenience Retail.
Apyx Medical Corporation to Participate in The Citizens Life Sciences Conference
08:00am, Wednesday, 18'th Feb 2026
CLEARWATER, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion®
Esperion to Participate in The 2026 Citizens Life Sciences Conference
08:00am, Wednesday, 18'th Feb 2026
ANN ARBOR, Mich., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted 2026 Citizens Life Sciences Conference on March 11,
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of First Citizens BancShares, Inc. - FCNCA
04:59pm, Tuesday, 17'th Feb 2026
NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of First Citizens BancShares, Inc. (“First Citizens” or the “Company”) (NASDAQ: FCNCA).
